Andreas Schmidt (Phd.)

At BigOmics, we are committed to empowering researchers in omics data analysis. Our Omics Playground is an intelligent omics data analysis platform that empowers biologists to perform complex analysis and visualization themselves and helps bioinformaticians delegate routine analysis. Governed self-service bioinformatics provides you with a powerful solution to fast-track your bioinformatics needs.

H3 Health Hub - A Helmholtz Transfer Academy - is a joint program of the Helmholtz Center for Infection Research (HZI), German Cancer Research Center (DKFZ), German Center for Neurodegenerative Diseases (DZNE), Helmholtz Center Dresden-Rossendorf (HZDR), Helmholtz Munich and Max Delbrück Center for Molecular Medicine (MDC). Together, we enable entrepreneurs to successfully transfer results from lab into business.

Developer of genome-based technologies to detect disorders and identify disease-specific genetic markers. Our approach uniquely identifies single-cell patterns in circular DNA, i.e., the Circulome(TM), to diagnose, prevent, and treat disorders associated with topological and genetic changes in DNA.

Springboard Health Angels is a Berlin-based business angel group that invests in early-stage life sciences startups, with a focus on health tech

Ceidos developed the C-Netics to fully automate cell expansion monitoring in a closed system. This ensures better outcomes and reduces the process’ costs as contamination risk is prevented and manual handling is drastically reduced.

AYOXXA - The translational proteomics company AYOXXA Biosystems GmbH, based in Cologne (Germany), is an international biotech company focused on the development of its proprietary beads-on-a-chip technology for advanced protein analysis. LUNARIS™. AYOXXA’s innovative multiplex protein analysis platform is a fully integrated system designed for the parallel analysis of multiple biomarkers in picogram amounts of biological samples, allowing scientists to gain a maximum of high quality and reproducible insights. LUNARIS™ is fully scalable, with integrated, image-based quality control and transparent data processing and management, enabling translational proteomics by addressing all the needs from basic to clinical research and development. AYOXXA is commercializing and expanding a portfolio of detection kits covering ophthalmology, model-to-man and immuno-oncology applications.

GAIN ist eine Gemeinschaftsinitiative der Alexander von Humboldt-Stiftung (AvH), des Deutschen Akademischen Austauschdienstes (DAAD) und der Deutschen Forschungsgemeinschaft (DFG). Die Fraunhofer-Gesellschaft, Helmholtz-Gemeinschaft Deutscher Forschungseinrichtungen, die Max-Planck-Gesellschaft, die Leibniz-Gemeinschaft, die Studienstiftung des deutschen Volkes e.V. und die Hochschulrektorenkonferenz sind als assoziierte Mitglieder beigetreten. Sie unterstützt sowohl die Rückkehr von Wissenschaftler/innen auf interessante Positionen in Europa, als auch das Kontakthalten und die Zusammenarbeit mit denjenigen Wissenschaftlerinnen und Wissenschaftlern, die sich für einen längeren oder dauerhaften Aufenthalt im US-Wissenschaftssystem entschieden haben. GAIN versteht sich als Werkzeug für deutsche Wissenschaftler/innen in Nordamerika, die an einer Fortsetzung ihrer Laufbahn in Deutschland und Europa interessiert sind

The Health + Life Science Alliance Heidelberg Mannheim combines leading research in the areas of medicine, life sciences and medical technology with outstanding cooperation structures and excellent patient care. The aim of this Alliance is to foster the further development of a leading life science region through recruitment of top talents, strengthening areas of excellence with platforms and flagship projects, and promoting young scientists through cross-institutional research programs. The Alliance bridges seven internationally highly renowned institutions in the Rhine-Neckar region: Heidelberg University and its two medical faculties, the University Hospital Heidelberg (UKHD), the University Hospital Mannheim (UMM), the German Cancer Research Center (DKFZ), the European Molecular Biology Laboratory (EMBL), the Max Planck Institute for Medical Research and the Central Institute of Mental Health (ZI). Embedded in a dynamic economic environment including major pharmaceutical, chemistry and technology companies as well as more than 400 small and medium-sized enterprises in the biotech and healthcare industry, the Alliance also aims to contribute to new research-driven start-up initiatives. The Health + Life Science Alliance is strongly supported by the Innovation Campus strategy of the state of Baden-Württemberg.

At BigOmics, we are committed to empowering researchers in omics data analysis. Our Omics Playground is an intelligent omics data analysis platform that empowers biologists to perform complex analysis and visualization themselves and helps bioinformaticians delegate routine analysis. Governed self-service bioinformatics provides you with a powerful solution to fast-track your bioinformatics needs.

Picus Capital is an early-stage technology investment firm with a long-term investment philosophy. We work together with daring technology companies to build successful, global companies challenging the status quo and shaping tomorrow

H3 Health Hub - A Helmholtz Transfer Academy - is a joint program of the Helmholtz Center for Infection Research (HZI), German Cancer Research Center (DKFZ), German Center for Neurodegenerative Diseases (DZNE), Helmholtz Center Dresden-Rossendorf (HZDR), Helmholtz Munich and Max Delbrück Center for Molecular Medicine (MDC). Together, we enable entrepreneurs to successfully transfer results from lab into business.

Developer of genome-based technologies to detect disorders and identify disease-specific genetic markers. Our approach uniquely identifies single-cell patterns in circular DNA, i.e., the Circulome(TM), to diagnose, prevent, and treat disorders associated with topological and genetic changes in DNA.